Revance Therapeutics Inc (RVNC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Revance Therapeutics Inc (RVNC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7327
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fasciitis among others. It also provides RT001, a topical gel formulation of daxibotulinumtoxinA, which is designed to eliminate the use of needles. Revance Therapeutics develops products for multiple aesthetic and therapeutic applications. The company utilizes TransMTS platform technology for the development of its products. It offers products for dermatology, neurology, musculoskeletal disorders, urology and ophthalmology. Revance Therapeutics is headquartered in Newark, California, the US.

Revance Therapeutics Inc (RVNC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Revance Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Equity Offering 13
Revance Therapeutics Plans to Raise upto USD125 Million in Public Offering of Shares 13
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 14
Revance Therapeutics Raises USD134.6 Public Offering of Shares 16
Revance Therapeutics Completes IPO For US$110.4 Million 18
Revance Therapeutics Inc – Key Competitors 20
Revance Therapeutics Inc – Key Employees 21
Revance Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 02, 2018: Revance releases second quarter 2018 results 23
May 08, 2018: Revance Releases First Quarter 2018 Results 24
Feb 28, 2018: Revance Announces Fourth Quarter and Full Year 2017 Financial Results 25
Aug 03, 2017: Revance Releases Second Quarter 2017 Results 26
May 09, 2017: Revance Releases First Quarter 2017 Results 27
Feb 27, 2017: Revance Releases Fourth Quarter and Full Year 2016 Results 28
Corporate Communications 30
Oct 11, 2018: Revance Therapeutics appoints Tobin C. Schilke as chief financial officer 30
Sep 20, 2018: Revance receives great place to work Certification 31
May 09, 2018: Revance Therapeutics Announces Two Recent Additions to Its Management Team 32
May 01, 2018: Revance Therapeutics Appoints Caryn McDowell As SVP, General Counsel & Corporate Secretary 33
Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors 34
Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Revance Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Revance Therapeutics Plans to Raise upto USD125 Million in Public Offering of Shares 13
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 14
Revance Therapeutics Raises USD134.6 Public Offering of Shares 16
Revance Therapeutics Completes IPO For US$110.4 Million 18
Revance Therapeutics Inc, Key Competitors 20
Revance Therapeutics Inc, Key Employees 21
Revance Therapeutics Inc, Subsidiaries 22

List of Figures
Revance Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Revance Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Revance Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Revance Therapeutics Inc (RVNC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Motif Bio Plc (MTFB):製薬・医療:M&Aディール及び事業提携情報
    Summary Motif Bio Plc (Motif Bio), formerly Motif Bio Ltd, is a clinical-stage biopharmaceutical company that focuses on the development of novel antibiotics to treat patients with infections caused by multi-drug resistant bacteria. The company develops Iclaprim, a targeted Gram-positive1 antibiotic …
  • Acerus Pharmaceuticals Corp (ASP):製薬・医療:M&Aディール及び事業提携情報
    Summary Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses on providing men’s and women’s health. The company uses its proprietary drug delivery technology platforms, which in …
  • Fairfax Media Limited:企業の戦略・SWOT・財務情報
    Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Stantec Inc (STN)-エネルギー分野:企業M&A・提携分析
    Summary Stantec Inc. (Stantec) is a consulting services company offering architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engineering, landscape architectu …
  • Middlesex Water Company (MSEX):企業の財務・戦略的SWOT分析
    Summary Middlesex Water Company (Middlesex Water) is a provider of water utility services. The company's services include water production, treatment and distribution, regulated and non-regulated water and wastewater utility services, wastewater system maintenance and working to promote economic dev …
  • MicroStrategy Inc (MSTR):企業の財務・戦略的SWOT分析
    MicroStrategy Inc (MSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gene Techno Science Co Ltd (4584)-製薬・医療分野:企業M&A・提携分析
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for cancer, intractable diseases and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-001 for immunological disease and oncology; GND-004, f …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Groupe Le Duff S.A.(Foodservice):企業の戦略・SWOT・財務情報
    Groupe Le Duff S.A.(Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Groupe Le Duff S.A.(Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Societatea Nationala Nuclearelectrica SA (SNN):電力:M&Aディール及び事業提携情報
    Summary Societatea Nationala Nuclearelectrica SA (SNN) is a state owned power generating company. It generates nuclear power and heat using nuclear fission and also manufactures nuclear fuel. SNN is the only company producing electricity based on nuclear technology in Romania. It also produces nucle …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Turkiye Petrol Rafinerileri AS (TUPRS):企業の財務・戦略的SWOT分析
    Turkiye Petrol Rafinerileri AS (TUPRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Pt Bank Central Asia Tbk:企業の戦略・SWOT・財務分析
    Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fujirebio Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that develops, manufactures and markets in-vitro diagnostic products and biomarker assays. The company’s products include manual kits, EIA kits, OEM custom solutions, multi-constituent controls, …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Triumph Group Inc:企業のM&A・事業提携・投資動向
    Triumph Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triumph Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Frontera Energy Corp (FEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Frontera Energy Corp (Frontera), formerly Pacific Exploration & Production Corporation, is an upstream energy company. It carries out exploration, development and production of natural gas and crude oil. The company’s major assets include heavy oilfields of Quifa SW, Jaspe, Cajua, Quifa Nort …
  • Royal Caribbean Cruises Ltd.:戦略・SWOT・企業財務分析
    Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report Summary Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Petropavlovsk PLC:企業の戦略・SWOT・財務情報
    Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report Summary Petropavlovsk PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Torm Plc (TRMD A):石油・ガス:M&Aディール及び事業提携情報
    Summary Torm Plc (Torm) is a shipping company serving the oil and gas sector. It offers a range of transportation services through its affiliated companies. The company undertakes transportation of refined oil products such as gasoline, jet fuel, naphtha, gas oil and fuel oil through its product tan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆